U.S. Healthcare Personal Protective Equipment Market Size, Share & Trends Analysis Report By Product (Hand Protection, Respiratory Protection), By End Use (Hospitals, Home Healthcare), And Segment Forecasts, 2020 - 2027
This report can be delivered to the clients within 48 Business Hours
U.S. Healthcare Personal Protective Equipment Market Growth & Trends
The U.S. healthcare personal protective equipment market size is anticipated to reach USD 13.2 billion by 2027, according to a new report by Grand View Research, Inc., expanding at a CAGR of 29.1% from 2020 to 2027. The aging population is expected to augment the demand for healthcare services, which, in turn, is expected to boost the medical-grade PPE demand over the coming years.
PPE is used by medical practitioners to protect their skin and exposed mucous membranes from exposure to contaminated blood or other potentially infectious bodily fluids/materials. An increasing number of hospital-induced infections, coupled with rising educational campaigns organized by the OSHA on occupational exposures, is expected to drive demand.
Healthcare spending in the U.S. has been increasing considerably since the past few years. Demand for healthcare services and products has led to increased use of healthcare personal protective equipment. In addition, the growing geriatric population in the country is anticipated to boost healthcare spending over the forecast period.
According to the Centers for Disease Control and Prevention, 60% of the U.S. adult population has chronic conditions and over 40% of the adult population has two or more chronic conditions. This has led to hospitals hiring more staff, opening new sites, and extending working hours, which has resulted in creating opportunities for PPE manufacturers.
U.S. Healthcare Personal Protective Equipment Market Report Highlights
U.S. Healthcare Personal Protective Equipment Market Growth & Trends
The U.S. healthcare personal protective equipment market size is anticipated to reach USD 13.2 billion by 2027, according to a new report by Grand View Research, Inc., expanding at a CAGR of 29.1% from 2020 to 2027. The aging population is expected to augment the demand for healthcare services, which, in turn, is expected to boost the medical-grade PPE demand over the coming years.
PPE is used by medical practitioners to protect their skin and exposed mucous membranes from exposure to contaminated blood or other potentially infectious bodily fluids/materials. An increasing number of hospital-induced infections, coupled with rising educational campaigns organized by the OSHA on occupational exposures, is expected to drive demand.
Healthcare spending in the U.S. has been increasing considerably since the past few years. Demand for healthcare services and products has led to increased use of healthcare personal protective equipment. In addition, the growing geriatric population in the country is anticipated to boost healthcare spending over the forecast period.
According to the Centers for Disease Control and Prevention, 60% of the U.S. adult population has chronic conditions and over 40% of the adult population has two or more chronic conditions. This has led to hospitals hiring more staff, opening new sites, and extending working hours, which has resulted in creating opportunities for PPE manufacturers.
U.S. Healthcare Personal Protective Equipment Market Report Highlights
- Based on product, protective clothing is anticipated to witness significant growth over the coming years owing to rising prevalence of the novel coronavirus, coupled with skyrocketing prices of isolation gowns because of the ban on imports and unavailability of raw materials
- The respiratory protection segment is projected to expand at the fastest CAGR of 62.0% from 2020 to 2027 on account of rising demand for N95 and surgical masks, along with the introduction of Defence Production Act by the U.S. government
- The hand protection segment held the largest share of 63.1% in 2019 due to the rise in the number of hospital admissions, coupled with the rising prevalence of skin allergies by latex gloves
- By end-use, the hospital segment held the largest share of 54.0% in 2019 owing to increase in healthcare spending and cosmetic surgeries in the country
- Key players in the market are focusing on upscaling their manufacturing capacities, acquisitions/partnerships, and product innovation in order to gain a competitive advantage and develop a strong foothold in the industry space.
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Research Methodology
1.2 Research Scope and Assumptions
1.3 Market Segmentation & Scope
1.4 Information Procurement
1.4.1 Purchased Database
1.4.2 GVR’s Internal Database
1.4.3 Secondary Sources
1.4.4 Third Party Perspective
1.4.5 Primary Research
1.5 Information Analysis
1.5.1 Data Analysis Models
1.6 Market Formulation and Data Visualization
1.7 Data Validation & Publishing
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
CHAPTER 3 U.S. MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Lineage Outlook
3.1.1 Global Personal Protective Equipment Market Outlook
3.2 Penetration & Growth Prospects Mapping
3.3 Industry Value Chain Analysis
3.3.1 Growing preference for e-commerce
3.3.2 List of Key End Users
3.4 Technology Overview
3.5 Regulatory Framework
3.5.1 U.S. Food and Drug Administration (FDA) Regulations
3.5.1.1 Surgical Masks (Face Masks)
3.5.1.2 N95 Respirators
3.5.1.3 Medical Gloves
3.5.1.4 Medical Gowns
3.5.1.5 21 CFR 878.4040
3.5.1.6 21 CFR 878.4460
3.5.1.7 21 CFR 880.6250
3.5.2 Centers for Disease Control and Prevention (CDC), and National Institute for Occupational Safety and Health (NIOSH) Regulations
3.5.2.1 42 CFR Part 84 Respiratory Protective Devices
3.5.3 ASTM INTERNATIONAL STANDARDS
3.5.3.1 ASTM F2407 - 06(2013) E1: STANDARD Specification for Surgical Gowns Intended for Use in Healthcare Facilities
3.5.3.2 ASTM D5250 - 19: Standard Specification for Poly (vinyl chloride) Gloves for Medical Application
3.5.4 International Organization for Standardization (ISO) STANDARDS
3.5.4.1 ISO 10282:2014: Single-use sterile rubber surgical gloves - Specification
3.5.4.2 ISO 11193-1:2008: Single-use medical examination gloves - Part 1: Specification for gloves made from rubber latex or rubber solution
3.5.4.3 ISO 11193-2:2006: Single-use medical examination gloves - Part 2: Specification for gloves made from poly (vinyl chloride)
3.5.5 Association for the Advancement of Medical Instrumentation (AAMI) STANDARDS
3.5.5.1 ANSI/AAMI PB70:2012
3.6 Market Dynamics
3.6.1 Market Driver Analysis
3.6.1.1 Rising healthcare expenditures & employment rates
3.6.1.2 Rising awareness pertaining to healthcare-associated infections
3.6.1.3 Rising technological advancements and digitalization to connect PPE suppliers to end-users
3.6.2 Market Restraint Analysis
3.6.2.1 Demand supply gap due to COVID-19 pandemic
3.6.3 Industry Challenges
3.6.3.1 Raw material shortages
3.7 Business Environment Analysis: U.S. Healthcare PPE Market
3.7.1 Industry Analysis - Porter’s Analysis
3.7.1.1 Supplier power
3.7.1.2 Threat of new entrants
3.7.1.3 Competitive rivalry
3.7.1.4 Threat of substitutes
3.7.1.5 Buyer power
3.7.2 PESTEL Analysis
3.7.2.1 Political
3.7.2.2 Economic
3.7.2.3 Social
3.7.2.4 Technological
3.7.2.5 Environmental
3.7.2.6 Legal
3.7.3 Major Deals & Strategic Alliances
CHAPTER 4 COVID-19 IMPACT ANALYSIS
4.1 General Overview
4.1.1 Cases and deaths, by state
4.1.2 Cases and deaths among healthcare personnel
4.1.3 Testing Data in the U.S.
4.2 New Regulations/ Relaxations/ Policy Changes
4.2.1 Products used in the COVID-19 market study (Section 301 Tariff and Exclusion Information)
4.3 Import/Export Scenario
4.4 Dependence of the U.S. Economy on Manufacturing and Supply Chains based in China
4.5 Major Deals/Strategic Alliances/Product Innovations/Market Entrants
CHAPTER 5 FORECAST FACTORS ANALYSIS
5.1 Coronavirus Death Statistics, Ease in Lockdowns Over Coming Months
5.1.1 State Social Distancing Actions (as of June 18, 2020)
5.1.1.1 Adults at Higher Risk of Serious Illness if Infected with COVID-19 (Requires Hospitalization)
5.1.1.2 Reports of Long-Term Care Facility Cases and Deaths Related to COVID-19 (as of June 18, 2020)
5.2 Rising Demand for PPE in the U.S.
5.3 Increase in Keyword Search
5.4 Supply Chain Implications
5.5 PPE Products Price Hikes
5.6 Increase in Healthcare Employment Rates
5.7 Verbatims
CHAPTER 6 U.S. HEALTHCARE PPE: PRODUCT ESTIMATES & TREND ANALYSIS
6.1 U.S. Healthcare PPE Market: Product Movement Analysis, 2019 & 2027
6.2 Protective Clothing
6.2.1 U.S. Healthcare Protective Clothing market estimates and forecasts, 2016 - 2027 (USD Million)
6.2.2 U.S. Healthcare Protective Clothing market estimates and forecasts, By Product, 2016 - 2027 (USD Million)
6.3 Respiratory Protection
6.3.1 U.S. Healthcare Respiratory Protection market estimates and forecasts, 2016 - 2027 (USD Million)
6.3.2 U.S. Healthcare Respiratory Protection market estimates and forecasts, By Product, 2016 - 2027 (USD Million)
6.4 Face Protection
6.4.1 U.S. Healthcare FACE Protection market estimates and forecasts, 2016 - 2027 (USD Million)
6.5 Eye Protection
6.5.1 U.S. Healthcare Eye Protection market estimates and forecasts, 2016 - 2027 (USD Million)
6.6 Hand Protection
6.6.1 U.S. Healthcare Hand Protection market estimates and forecasts, 2016 - 2027 (USD Million)
6.6.2 U.S. Healthcare Hand Protection market estimates and forecasts, By Product, 2016 - 2027 (USD Million)
6.7 Others
6.7.1 U.S. Other Healthcare PPE market estimates and forecasts, 2016 - 2027 (USD Million)
CHAPTER 7 U.S. HEALTHCARE PPE MARKET: END-USE ESTIMATES & TREND ANALYSIS
7.1 U.S. Healthcare PPE Market: End-use Movement Analysis, 2019 & 2027
7.2 Hospitals
7.2.1 U.S. Healthcare PPE market estimates and forecasts, by Hospitals, 2016 - 2027 (USD Million)
7.3 Home Healthcare
7.3.1 U.S. Healthcare PPE market estimates and forecasts, by Home Healthcare, 2016 - 2027 (USD Million)
7.4 Outpatient/Primary Care Facilities
7.4.1 U.S. Healthcare PPE market estimates and forecasts, by Outpatient/Primary Care Facilities, 2016 - 2027 (USD Million)
7.5 Others
7.5.1 U.S. Healthcare PPE market estimates and forecasts, by Others, 2016 - 2027 (USD Million)
CHAPTER 8 COMPETITIVE ANALYSIS
8.1 Key Players & Recent Developments & Their Impact on the Industry
8.2 Key Company/Competition Categorization
8.3 Vendor Landscape
8.3.1 List of key distributors and channel partners
8.3.2 Key Customers
8.4 Public Companies
8.4.1 Company market position analysis
8.4.2 Company Market Share/Ranking Analysis
8.4.3 SWOT
8.5 Private Companies
8.5.1 List of companies and their geographical presence
CHAPTER 9 COMPANY PROFILES
9.1 3M
9.1.1 Company Overview
9.1.2 Financial Performance
9.1.3 Product benchmarking
9.2 Alpha Pro Tech
9.2.1 Company Overview
9.2.2 Financial Performance
9.2.3 Product benchmarking
9.2.4 Strategic Initiatives
9.3 Ansell Ltd.
9.3.1 Company Overview
9.3.2 Financial Performance
9.3.3 Product benchmarking
9.3.4 Strategic Initiatives
9.4 Medisca Inc.
9.4.1 Company Overview
9.4.2 Product benchmarking
9.5 O&M Halyard, Inc.
9.5.1 Company Overview
9.5.2 Financial Performance
9.5.3 Product benchmarking
9.6 DuPont de Nemours, Inc.
9.6.1 Company Overview
9.6.2 Financial Performance
9.6.3 Product benchmarking
9.6.4 Strategic Initiatives
9.7 Cardinal Health
9.7.1 Company Overview
9.7.2 Financial Performance
9.7.3 Product benchmarking
9.8 Medline Industries, Inc.
9.8.1 Company Overview
9.8.2 Financial Performance
9.8.3 Product benchmarking
9.8.4 Strategic Initiatives
9.9 Kimberly-Clark Corporation
9.9.1 Company Overview
9.9.2 Financial Performance
9.9.3 Product benchmarking
9.10 Honeywell International Inc.
9.10.1 Company Overview
9.10.2 Financial Performance
9.10.3 Product Benchmarking
9.10.4 Strategic Initiatives
1.1 Research Methodology
1.2 Research Scope and Assumptions
1.3 Market Segmentation & Scope
1.4 Information Procurement
1.4.1 Purchased Database
1.4.2 GVR’s Internal Database
1.4.3 Secondary Sources
1.4.4 Third Party Perspective
1.4.5 Primary Research
1.5 Information Analysis
1.5.1 Data Analysis Models
1.6 Market Formulation and Data Visualization
1.7 Data Validation & Publishing
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
CHAPTER 3 U.S. MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Lineage Outlook
3.1.1 Global Personal Protective Equipment Market Outlook
3.2 Penetration & Growth Prospects Mapping
3.3 Industry Value Chain Analysis
3.3.1 Growing preference for e-commerce
3.3.2 List of Key End Users
3.4 Technology Overview
3.5 Regulatory Framework
3.5.1 U.S. Food and Drug Administration (FDA) Regulations
3.5.1.1 Surgical Masks (Face Masks)
3.5.1.2 N95 Respirators
3.5.1.3 Medical Gloves
3.5.1.4 Medical Gowns
3.5.1.5 21 CFR 878.4040
3.5.1.6 21 CFR 878.4460
3.5.1.7 21 CFR 880.6250
3.5.2 Centers for Disease Control and Prevention (CDC), and National Institute for Occupational Safety and Health (NIOSH) Regulations
3.5.2.1 42 CFR Part 84 Respiratory Protective Devices
3.5.3 ASTM INTERNATIONAL STANDARDS
3.5.3.1 ASTM F2407 - 06(2013) E1: STANDARD Specification for Surgical Gowns Intended for Use in Healthcare Facilities
3.5.3.2 ASTM D5250 - 19: Standard Specification for Poly (vinyl chloride) Gloves for Medical Application
3.5.4 International Organization for Standardization (ISO) STANDARDS
3.5.4.1 ISO 10282:2014: Single-use sterile rubber surgical gloves - Specification
3.5.4.2 ISO 11193-1:2008: Single-use medical examination gloves - Part 1: Specification for gloves made from rubber latex or rubber solution
3.5.4.3 ISO 11193-2:2006: Single-use medical examination gloves - Part 2: Specification for gloves made from poly (vinyl chloride)
3.5.5 Association for the Advancement of Medical Instrumentation (AAMI) STANDARDS
3.5.5.1 ANSI/AAMI PB70:2012
3.6 Market Dynamics
3.6.1 Market Driver Analysis
3.6.1.1 Rising healthcare expenditures & employment rates
3.6.1.2 Rising awareness pertaining to healthcare-associated infections
3.6.1.3 Rising technological advancements and digitalization to connect PPE suppliers to end-users
3.6.2 Market Restraint Analysis
3.6.2.1 Demand supply gap due to COVID-19 pandemic
3.6.3 Industry Challenges
3.6.3.1 Raw material shortages
3.7 Business Environment Analysis: U.S. Healthcare PPE Market
3.7.1 Industry Analysis - Porter’s Analysis
3.7.1.1 Supplier power
3.7.1.2 Threat of new entrants
3.7.1.3 Competitive rivalry
3.7.1.4 Threat of substitutes
3.7.1.5 Buyer power
3.7.2 PESTEL Analysis
3.7.2.1 Political
3.7.2.2 Economic
3.7.2.3 Social
3.7.2.4 Technological
3.7.2.5 Environmental
3.7.2.6 Legal
3.7.3 Major Deals & Strategic Alliances
CHAPTER 4 COVID-19 IMPACT ANALYSIS
4.1 General Overview
4.1.1 Cases and deaths, by state
4.1.2 Cases and deaths among healthcare personnel
4.1.3 Testing Data in the U.S.
4.2 New Regulations/ Relaxations/ Policy Changes
4.2.1 Products used in the COVID-19 market study (Section 301 Tariff and Exclusion Information)
4.3 Import/Export Scenario
4.4 Dependence of the U.S. Economy on Manufacturing and Supply Chains based in China
4.5 Major Deals/Strategic Alliances/Product Innovations/Market Entrants
CHAPTER 5 FORECAST FACTORS ANALYSIS
5.1 Coronavirus Death Statistics, Ease in Lockdowns Over Coming Months
5.1.1 State Social Distancing Actions (as of June 18, 2020)
5.1.1.1 Adults at Higher Risk of Serious Illness if Infected with COVID-19 (Requires Hospitalization)
5.1.1.2 Reports of Long-Term Care Facility Cases and Deaths Related to COVID-19 (as of June 18, 2020)
5.2 Rising Demand for PPE in the U.S.
5.3 Increase in Keyword Search
5.4 Supply Chain Implications
5.5 PPE Products Price Hikes
5.6 Increase in Healthcare Employment Rates
5.7 Verbatims
CHAPTER 6 U.S. HEALTHCARE PPE: PRODUCT ESTIMATES & TREND ANALYSIS
6.1 U.S. Healthcare PPE Market: Product Movement Analysis, 2019 & 2027
6.2 Protective Clothing
6.2.1 U.S. Healthcare Protective Clothing market estimates and forecasts, 2016 - 2027 (USD Million)
6.2.2 U.S. Healthcare Protective Clothing market estimates and forecasts, By Product, 2016 - 2027 (USD Million)
6.3 Respiratory Protection
6.3.1 U.S. Healthcare Respiratory Protection market estimates and forecasts, 2016 - 2027 (USD Million)
6.3.2 U.S. Healthcare Respiratory Protection market estimates and forecasts, By Product, 2016 - 2027 (USD Million)
6.4 Face Protection
6.4.1 U.S. Healthcare FACE Protection market estimates and forecasts, 2016 - 2027 (USD Million)
6.5 Eye Protection
6.5.1 U.S. Healthcare Eye Protection market estimates and forecasts, 2016 - 2027 (USD Million)
6.6 Hand Protection
6.6.1 U.S. Healthcare Hand Protection market estimates and forecasts, 2016 - 2027 (USD Million)
6.6.2 U.S. Healthcare Hand Protection market estimates and forecasts, By Product, 2016 - 2027 (USD Million)
6.7 Others
6.7.1 U.S. Other Healthcare PPE market estimates and forecasts, 2016 - 2027 (USD Million)
CHAPTER 7 U.S. HEALTHCARE PPE MARKET: END-USE ESTIMATES & TREND ANALYSIS
7.1 U.S. Healthcare PPE Market: End-use Movement Analysis, 2019 & 2027
7.2 Hospitals
7.2.1 U.S. Healthcare PPE market estimates and forecasts, by Hospitals, 2016 - 2027 (USD Million)
7.3 Home Healthcare
7.3.1 U.S. Healthcare PPE market estimates and forecasts, by Home Healthcare, 2016 - 2027 (USD Million)
7.4 Outpatient/Primary Care Facilities
7.4.1 U.S. Healthcare PPE market estimates and forecasts, by Outpatient/Primary Care Facilities, 2016 - 2027 (USD Million)
7.5 Others
7.5.1 U.S. Healthcare PPE market estimates and forecasts, by Others, 2016 - 2027 (USD Million)
CHAPTER 8 COMPETITIVE ANALYSIS
8.1 Key Players & Recent Developments & Their Impact on the Industry
8.2 Key Company/Competition Categorization
8.3 Vendor Landscape
8.3.1 List of key distributors and channel partners
8.3.2 Key Customers
8.4 Public Companies
8.4.1 Company market position analysis
8.4.2 Company Market Share/Ranking Analysis
8.4.3 SWOT
8.5 Private Companies
8.5.1 List of companies and their geographical presence
CHAPTER 9 COMPANY PROFILES
9.1 3M
9.1.1 Company Overview
9.1.2 Financial Performance
9.1.3 Product benchmarking
9.2 Alpha Pro Tech
9.2.1 Company Overview
9.2.2 Financial Performance
9.2.3 Product benchmarking
9.2.4 Strategic Initiatives
9.3 Ansell Ltd.
9.3.1 Company Overview
9.3.2 Financial Performance
9.3.3 Product benchmarking
9.3.4 Strategic Initiatives
9.4 Medisca Inc.
9.4.1 Company Overview
9.4.2 Product benchmarking
9.5 O&M Halyard, Inc.
9.5.1 Company Overview
9.5.2 Financial Performance
9.5.3 Product benchmarking
9.6 DuPont de Nemours, Inc.
9.6.1 Company Overview
9.6.2 Financial Performance
9.6.3 Product benchmarking
9.6.4 Strategic Initiatives
9.7 Cardinal Health
9.7.1 Company Overview
9.7.2 Financial Performance
9.7.3 Product benchmarking
9.8 Medline Industries, Inc.
9.8.1 Company Overview
9.8.2 Financial Performance
9.8.3 Product benchmarking
9.8.4 Strategic Initiatives
9.9 Kimberly-Clark Corporation
9.9.1 Company Overview
9.9.2 Financial Performance
9.9.3 Product benchmarking
9.10 Honeywell International Inc.
9.10.1 Company Overview
9.10.2 Financial Performance
9.10.3 Product Benchmarking
9.10.4 Strategic Initiatives
LIST OF TABLES
Table 1 List of Key End Users
Table 2 Employment, Unemployment, Openings, Hires, and Separations
Table 3 Cases and deaths, by state
Table 4 Cases and deaths among healthcare personnel (updated on June 22, 2020)
Table 5 Testing data in the U.S. (as of June 18, 2020)
Table 6 Products used in the COVID-19 market study (Section 301 tariff and exclusion information)
Table 7 List of companies that have started or upscaled their production of critical medical supplies to combat COVID-19
Table 8 U.S. healthcare protective clothing market estimates and forecasts, 2016 - 2027 (USD Million)
Table 9 U.S. healthcare protective clothing market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 10 U.S. healthcare respiratory protection market estimates and forecasts, 2016 - 2027 (USD Million)
Table 11 U.S. healthcare respiratory protection market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 12 U.S. healthcare face protection market estimates and forecasts, 2016 - 2027 (USD Million)
Table 13 U.S. healthcare face protection market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 14 U.S. healthcare eye protection market estimates and forecasts, 2016 - 2027 (USD Million)
Table 15 U.S. healthcare eye protection market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 16 U.S. healthcare hand protection market estimates and forecasts, 2016 - 2027 (USD Million)
Table 17 U.S. healthcare hand protection market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 18 U.S. other healthcare PPE market estimates and forecasts, 2016 - 2027 (USD Million)
Table 19 U.S. other healthcare PPE market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 20 U.S. healthcare PPE market estimates and forecasts, by hospitals, 2016 - 2027 (USD Million)
Table 21 U.S. healthcare PPE market estimates and forecasts, by home healthcare, 2016 - 2027 (USD Million)
Table 22 U.S. healthcare PPE market estimates and forecasts, by outpatient/primary care facilities, 2016 - 2027 (USD Million)
Table 23 U.S. healthcare PPE market estimates and forecasts, by others, 2016 - 2027 (USD Million)
Table 24 List of Key Distributors & Channel Partners
Table 25 Heat map analysis
Table 26 SWOT analysis of public companies
Table 27 List of key companies and their geographical presence
Table 1 List of Key End Users
Table 2 Employment, Unemployment, Openings, Hires, and Separations
Table 3 Cases and deaths, by state
Table 4 Cases and deaths among healthcare personnel (updated on June 22, 2020)
Table 5 Testing data in the U.S. (as of June 18, 2020)
Table 6 Products used in the COVID-19 market study (Section 301 tariff and exclusion information)
Table 7 List of companies that have started or upscaled their production of critical medical supplies to combat COVID-19
Table 8 U.S. healthcare protective clothing market estimates and forecasts, 2016 - 2027 (USD Million)
Table 9 U.S. healthcare protective clothing market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 10 U.S. healthcare respiratory protection market estimates and forecasts, 2016 - 2027 (USD Million)
Table 11 U.S. healthcare respiratory protection market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 12 U.S. healthcare face protection market estimates and forecasts, 2016 - 2027 (USD Million)
Table 13 U.S. healthcare face protection market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 14 U.S. healthcare eye protection market estimates and forecasts, 2016 - 2027 (USD Million)
Table 15 U.S. healthcare eye protection market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 16 U.S. healthcare hand protection market estimates and forecasts, 2016 - 2027 (USD Million)
Table 17 U.S. healthcare hand protection market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 18 U.S. other healthcare PPE market estimates and forecasts, 2016 - 2027 (USD Million)
Table 19 U.S. other healthcare PPE market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 20 U.S. healthcare PPE market estimates and forecasts, by hospitals, 2016 - 2027 (USD Million)
Table 21 U.S. healthcare PPE market estimates and forecasts, by home healthcare, 2016 - 2027 (USD Million)
Table 22 U.S. healthcare PPE market estimates and forecasts, by outpatient/primary care facilities, 2016 - 2027 (USD Million)
Table 23 U.S. healthcare PPE market estimates and forecasts, by others, 2016 - 2027 (USD Million)
Table 24 List of Key Distributors & Channel Partners
Table 25 Heat map analysis
Table 26 SWOT analysis of public companies
Table 27 List of key companies and their geographical presence
LIST OF FIGURES
Fig. 1 Market Segmentation
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Primary Research Process
Fig. 5 Market research approaches - Bottom-Up Approach
Fig. 6 Market research approaches - Top-Down Approach
Fig. 7 Market research approaches - Combined Approach
Fig. 8 Market Outlook (USD Million)
Fig. 9 Segment Outlook
Fig. 10 Competitive Insights
Fig. 11 Penetration and Growth Prospect Mapping
Fig. 12 Industry Value Chain Analysis
Fig. 13 Market Driver Analysis
Fig. 14 Healthcare Expenditure in the U.S., 2010 to 2025 (E) (USD Million)
Fig. 15 Number of CLABSI Events Observed in Various Healthcare Settings in the U.S., 2016 to 2018
Fig. 16 Number of CAUTI events observed in various healthcare settings in the U.S., 2016 to 2018
Fig. 17 Market Restraint Analysis
Fig. 18 U.S. exports and imports in 2019, by product, buyer and source
Fig. 19 U.S. healthcare PPE market: product movement analysis, 2019 & 2027
Fig. 20 U.S. Healthcare PPE Market: End-use Movement Analysis, 2019 & 2027
Fig. 21 Key Company/Competition Categorization
Fig. 1 Market Segmentation
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Primary Research Process
Fig. 5 Market research approaches - Bottom-Up Approach
Fig. 6 Market research approaches - Top-Down Approach
Fig. 7 Market research approaches - Combined Approach
Fig. 8 Market Outlook (USD Million)
Fig. 9 Segment Outlook
Fig. 10 Competitive Insights
Fig. 11 Penetration and Growth Prospect Mapping
Fig. 12 Industry Value Chain Analysis
Fig. 13 Market Driver Analysis
Fig. 14 Healthcare Expenditure in the U.S., 2010 to 2025 (E) (USD Million)
Fig. 15 Number of CLABSI Events Observed in Various Healthcare Settings in the U.S., 2016 to 2018
Fig. 16 Number of CAUTI events observed in various healthcare settings in the U.S., 2016 to 2018
Fig. 17 Market Restraint Analysis
Fig. 18 U.S. exports and imports in 2019, by product, buyer and source
Fig. 19 U.S. healthcare PPE market: product movement analysis, 2019 & 2027
Fig. 20 U.S. Healthcare PPE Market: End-use Movement Analysis, 2019 & 2027
Fig. 21 Key Company/Competition Categorization
